AURX

Nuo Therapeutics (QB) (AURX)

Nuo Therapeutics Inc (QB)

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:AURX

1 2 3 4 5 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/12	05 : 26	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:AURX	Nuo Therapeutics Inc (QB)
2024/05/23	01 : 40	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	USOTC:AURX	Nuo Therapeutics Inc (QB)
2024/05/22	04 : 13	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:AURX	Nuo Therapeutics Inc (QB)
2024/05/22	04 : 11	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:AURX	Nuo Therapeutics Inc (QB)
2024/05/21	21 : 30	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:AURX	Nuo Therapeutics Inc (QB)
2024/05/16	06 : 00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:AURX	Nuo Therapeutics Inc (QB)
2024/02/15	03 : 58	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	USOTC:AURX	Nuo Therapeutics Inc (QB)
2024/02/13	07 : 33	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	USOTC:AURX	Nuo Therapeutics Inc (QB)
2023/12/23	00 : 01	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	USOTC:AURX	Nuo Therapeutics Inc (QB)
2023/12/21	04 : 18	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	USOTC:AURX	Nuo Therapeutics Inc (QB)
2023/12/21	04 : 04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:AURX	Nuo Therapeutics Inc (QB)
2023/12/21	04 : 03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:AURX	Nuo Therapeutics Inc (QB)
2023/12/20	23 : 02	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:AURX	Nuo Therapeutics Inc (QB)
2023/11/21	06 : 30	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:AURX	Nuo Therapeutics Inc (QB)
2023/11/15	23 : 37	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	USOTC:AURX	Nuo Therapeutics Inc (QB)
2023/08/09	03 : 15	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	USOTC:AURX	Nuo Therapeutics Inc (QB)
2023/08/04	05 : 18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:AURX	Nuo Therapeutics Inc (QB)
2023/08/04	05 : 17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:AURX	Nuo Therapeutics Inc (QB)
2023/08/04	05 : 15	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:AURX	Nuo Therapeutics Inc (QB)
2023/05/16	06 : 10	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:AURX	Nuo Therapeutics Inc (QB)
2023/04/17	19 : 08	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:AURX	Nuo Therapeutics Inc (QB)
2022/11/15	08 : 44	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:AURX	Nuo Therapeutics Inc (QB)
2022/11/05	06 : 28	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:AURX	Nuo Therapeutics Inc (QB)
2022/10/20	21 : 36	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	USOTC:AURX	Nuo Therapeutics Inc (QB)
2022/10/20	21 : 34	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	USOTC:AURX	Nuo Therapeutics Inc (QB)
2022/08/30	21 : 16	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:AURX	Nuo Therapeutics Inc (QB)
2022/08/11	02 : 29	Edgar (US Regulatory)	Amended Quarterly Report (10-q/a)	USOTC:AURX	Nuo Therapeutics Inc (QB)
2022/08/09	05 : 49	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:AURX	Nuo Therapeutics Inc (QB)
2022/07/05	21 : 03	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	USOTC:AURX	Nuo Therapeutics Inc (QB)
2022/07/05	21 : 02	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	USOTC:AURX	Nuo Therapeutics Inc (QB)